United States · Venture startup

Who invested in PATH EX

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

HealthcareMedical Devices

Funding summaryUpdated 26 Oct 2026

$5.0Mraised across 1 round since 2025, from 1 source

Latest round
Venture, $5.0MMay 2025
Investors
4
See who backed them

The rounds

  1. May 2025
    Venture$5.0M

    Source recordedSEC filing: $8.2M sold, first sale Apr 2025

Everyone who backed them

MassChallengeAccelerator1round
Innova MemphisGovernment1round
IAG Capital PartnersPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 4 firms list PATH EX as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Houston Angel NetworkAngel networkPer its own site
America's Seed FundGovernmentPer its own site
Star51 CapitalVC firmPer its own site
Symbiotic VenturesVC firmPer its own site

Quick answers about PATH EX

Who invested in PATH EX?

PATH EX's investors include National Science Foundation, MassChallenge, Innova Memphis and IAG Capital Partners.

How much has PATH EX raised?

PATH EX has raised $5.0M across 1 round since 2025.

When did PATH EX last raise?

PATH EX's most recent round was a Venture of $5.0M in May 2025.

What was PATH EX's biggest round?

Its most recent round, $5.0M in May 2025, is also its largest on record.

Who backed PATH EX first?

PATH EX's first round on record, in May 2025, was backed by National Science Foundation, MassChallenge and Innova Memphis and 1 others.

What stage is PATH EX at?

PATH EX's latest named round is a Venture, in May 2025.

Where is PATH EX based?

PATH EX is based in the United States.

Companies like PATH EX

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.